All posts by imreal

A Guide to New Clinical Trial Requirements Management Report


WCG CenterWatch

WCG CenterWatch

With ICH E8(R1) set to be adopted in June 2020, how one plans, designs and conducts clinical trials will look different than they do today. Be ready to implement the new guidelines.

The Revised ICH E8: A Guide to New Clinical Trial Requirements management report shows readers how to leverage the revised guidelines’ quality-by-design approaches, expanded study designs and data source considerations. With this knowledge, one can adapt, continuing to provide a quality-driven framework that leads to efficient and timely decision making, and ultimately to improved access to safe and effective drugs. This management report will:


  • Explain the scope and general principles of the ICH E8(R1) guideline
  • Describe the impact on current research practices that could influence SOPs, procedures, processes and documentation
  • Describe the framework and approaches for identifying critical-to-quality factors
  • Identify clinical development areas that may be impacted by the adoption of the ICH E8(R1) guideline and approaches for compliance

Prepare for ICH E8(R1) now, June is only a few months away.

Management Report Details:

The Revised ICH E8:

A Guide to New Clinical Trial Requirements

A CenterWatch Book

https://www.centerwatch.com/products/category/1105-books/product/435-the-revised-ich-e8-a-guide-to-new-clinical-trial-requirements-pdf

Management Report PDF:

$397

Easy Ways to Order:

Online: https://www.centerwatch.com/products/category/1105-books/product/435-the-revised-ich-e8-a-guide-to-new-clinical-trial-requirements-pdf

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

Inc. 5000 Series Texas 2020 Ranks Insogna CPA as a Fastest-Growing Company


We are very excited to be recognized by Inc. Magazine”, said Chase Insogna, Founder and CEO of Insogna CPA.

Inc. magazine today revealed that Insogna CPA is No. 171 on its inaugural Inc. 5000 Series: Texas list of The Most Inspiring Companies in Texas. The most prestigious ranking of the fastest-growing Texas-based private companies. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Texas economy’s most dynamic segment—its independent small businesses.

“We are very excited to be recognized by Inc. Magazine”, said Chase Insogna, Founder and CEO of Insogna CPA. “Our educated team of experienced professionals work diligently every day to serve our valued customers, which has led to significant year-over-year growth at Insogna CPA”, he continued. “We are extremely proud of our team’s dedication and look forward to the continued growth of the company and providing valuable expertise to our customers.”

The companies included in this list show stunning rates of growth across all industries in Texas with an average growth rate of 294 percent, employing 36,000 people and adding $11 billion to the Texas economy. Companies based in the largest metro areas Dallas, Houston, Austin, and San Antonio brought in the highest revenue overall. A full list of companies included in the Inc. 5000 2019 may be found here: inc.com/inc5000-series-texas-2020.

“The companies on this list demonstrate just how much the small-business sector impacts Texas’s economy,” says Inc. Editor in Chief, Scott Omelianuk. “Across every single industry, these businesses have posted revenue and growth rates that are beyond impressive, further proving the tenacity of their founders and CEOs.”

About Insogna CPA

Insogna CPA delivers an integrated team of experts dedicated to helping small businesses under $20M with year-around accounting, tax strategy and wealth building. We tailor customized monthly packages to help grow your business with you – and help with individual taxes too. Our highly-trained team of professionals use tech-savvy solutions to create efficiencies and provide expertly designed and transparent advisory, coaching, planning and strategy. Insogna CPA is a Dave Ramsey Endorsed Local Provider (ELP); Top50 Cloud Accounting Firm; Inc5000 Series-Most Inspiring Companies in Texas; Top3 Accounting Firm by LocalBest; Intuit QuickBooks Certified ProAdvisor; Xero Advisor Certified; Platinum-Austin Green Business Leader; Member-American Institute of Certified Public Accountants (AICPA; Member-Texas Society of Certified Public Accountants (TSCPA). For more information, please visit https://insognacpa.com/

Share article on social media or email:

An interview with the Benefits Science Technologies Data Science Team Leader, Omid Nohadani


Dr. Nohadani is an optimization and machine learning scientist with a proven track record of developing algorithms and solutions for big-data environments affected by uncertainty and subjected to complex risk measures. He sits down to talk about how the latest innovations in data science provide plan sponsors with powerful new tools that help improve the visibility and analysis of their data and prescribe actions to improve their health plan.

1. What was your role prior to coming to Benefits Science Technologies?

A: Most recently, I worked as an Associate Professor of Industrial Engineering and Management Sciences at Northwestern University. In my research group, we studied dynamic optimization and analytics under uncertainty and risk, with applications in healthcare, supply chain management, analytics, and technology. In particular, we focused on data-driven dynamic systems that rely on human interaction or have decision-makers with complex risk requirements. I received my MS degree in physics from the University of Bonn, Germany and my Ph.D. in physics from the University of Southern California, Los Angeles. I then joined the Operations Research Center at MIT as a postdoctoral researcher, developing novel robust optimization algorithms. As a research fellow and instructor at the Department of Radiation Oncology at Harvard Medical School’s Massachusetts General Hospital, I conducted mathematical research on cancer treatment.

2. What is your role at BST?

A: I lead our data science team of highly talented Ph.Ds. and MSs., who work on core components of our products. Our research team integrates the cutting-edge developments from the scientific communities of optimization and machine learning with the requirements of practitioners to create methods and ultimately products that empower data-driven decisions beyond individual expertise. We leverage the newest research findings to not only analyze the plethora of data sources at BST but also provide predictive and – more importantly – prescriptive insights. This allows for optimal resource allocation and targeted treatments in a timely fashion while maintaining costs.

3. You’ve had a pretty varied career path, what attracted you to BST?

A: My goal as a data scientist is to push the boundaries of science and technology in order to expand our knowledge and to create solutions that affect the world positively. This endeavor typically requires three components: exposure to relevant problems, proximity to cutting-edge science, and access to the real-world, e.g., through observation and data. I have pursued this goal in academic settings for a number of years and realized that while the first two components are available, the access to real-world data is limited. Alternatively, many private organizations pose relevant questions and have access to observations but are often not closely connected to the newest scientific discoveries. At Benefits Science, I was delighted to find a productive combination of all three components in a unique setting as a research-driven endeavor with a mature business model, providing the ideal format to innovate for real-world settings. Moreover, the societal relevance of healthcare elevates the motivation on a personal level and its economic impact promises transformation.

4. Where do you see these capabilities being applied in the healthcare decision space?

A: Benefit plan design is traditionally centered on the expertise of decision-makers. Given the complexity of these products and possible combinations, plan designers resort to last year’s choices to inform the next designs in an iterative fashion. At BST, human expertise is built into an algorithm that leverages all data to provide the optimal design that meets all desired criteria while minimizing costs. BST’s technology is able to efficiently solve large-scale mathematical robust optimization problems that were not possible before. Similarly, risk management is currently guided by broad economic trend analysis and is rarely tailored to the studied cohort. At BST, cohort related factors are also accounted for to not only predict future risk factors of individual members but also to prescribe which proactive steps could advance members’ health and mitigate risks. This could only be made possible at BST by integrating cutting-edge machine learning techniques with the newest optimization algorithms.

5. Interesting, can you give a specific example of how that works?

A: Employers often offer additional wellness and preventive benefits. However, budgetary considerations constrain the portfolio of these benefits. The prescriptive nature of BST’s technologies allows us to optimally tailor the portfolio to a subgroup of employees who have different needs, instead of the current one-size-fits-all approach. For example, members with musculoskeletal problems will be distinguished from those who require dietary support and our methods would help employers best address those needs while maintaining budgets. Moreover, we leverage past performance data to recommend the set of providers who would optimally improve health outcomes.

6. How do you see these types of advancements impacting the future of healthcare analysis?

A: All aspects of healthcare-related decision making, from medicine, delivery, policy, supply chains, and economics are becoming increasingly more data-driven. At BST, we are developing solutions that affect many of these directions. Since accuracy, scalability, and interpretability is at the core of our research and products, I believe we are well equipped to address future challenges. For example, our interpretable care pathways are trained with past data and informed by experts’ knowledge, hence well positioned to curb the increasing occurrence of diabetes in a proactive fashion, improving patient’s health, reshaping treatment schedules, and managing costs. The abundance of data and the emergence of powerful methodologies makes it an exciting time to be a data scientist in healthcare.

About Benefits Science Technologies

BST provides data analytics software/analysis to help manage the risk of self-funded health plans. Plan holders improve their connection to data, empowering optimal decisions to control costs, and improve the quality of care for plan members. The company distributes these capabilities to employers directly, through brokers/consultants, or by association with carriers (stop-loss and voluntary benefits providers), benefits administrators, professional employer organizations, third party administrators, pharmacy benefit managers, and/or cost-containment providers.

Founded in 2012, the company is recognized as a world-leading research and applied science team, developing advanced analytics and robust optimization methodology for complex health insurance decisions. Our mission is to improve health outcomes while lowering costs by helping our clients uncover the details of their health plan – and providing actionable insights along with outcome predictions for the recommended decisions. Our strategy is to build world-class solutions based on cutting-edge scientific insights.

Media Contact

Benefits Science Technologies

Mark Hufham mhufham@benefitsscience.com

###

Share article on social media or email:

Waggl Offers Free 90-Day Use to Help Organizations Hear from Their People During the COVID-19 Crisis


Graphic illustrating how organizations and people adapt to change

Waggl’s Employee Voice Platform Helps Organizations Adapt to the “New Normal”

“In the midst of the challenges we currently face as individuals and leaders, I believe that our ability to rapidly learn from one another will be one of our greatest assets,” said Michael Papay, Co-founder and CEO, Waggl

Waggl today announced that, in order to help support organizations during the COVID-19 crisis, it is offering use of its Employee Voice platform for 90 days at no cost. Learn more here: http://www.waggl.com/covid-19. This is a stand-alone license with no contractual agreement.

Waggl is a robust employee engagement solution that utilizes Employee Voice to crowdsource real-time insight to drive faster action and alignment around critical business topics. By enabling a shared real-time dialogue around critical questions, Waggl rapidly surfaces and prioritizes insights, ideas, and information to help organizations maintain connection and reinforce a sense of community in the midst of uncertain times.

“In this time of great uncertainty, we want to help — and we believe that enabling organizations to maintain genuine connection and community with their employees is the most human and heartfelt way that we can provide support,” said Michael Papay, Co-founder and CEO, Waggl. “Listening to every voice has never been more crucial. In the midst of the challenges we currently face as individuals and leaders, I believe that our ability to rapidly learn from one another will be one of our greatest assets. Now, more than ever, it is critical for leaders to harness the wisdom of all the people within their organizations, as we adjust to the new normal.”

Right now, remote work and interrupted workflows are presenting steep challenges to how many organizations keep employees engaged and productive. By keeping people engaged, connected, and informed, Employee Voice is the most agile way to include people in authentic dialogue, and align teams around action.

“Organizations create a voice culture when they empower employees to share ideas and concerns about organizational improvements,” said Dr. Russell Robinson, Founder of Amplified Research. “This increases employees’ engagement in the company’s goals.”

Waggl’s COVID-19 response package includes:

  • Free use of Waggl for 90 days with 3 pre-loaded question sets
  • Complimentary 15-minute onboarding call
  • Comprehensive ‘Getting Started with Waggl” guide

“The truth is that the COVID-19 crisis has forever changed the landscape of business and work – and in order to co-create the future, we can’t go backward,” said Papay. “There is a tremendous amount of power and comfort in our collective intelligence. Building a continuous listening process that asks people for their input, in and of itself, helps to create an environment of mutual trust in which people feel more safe and empowered to do their jobs.”

To learn more about Waggl, please visit https://www.waggl.com/.

About Waggl

For HR leaders who need to measure, and truly improve engagement, Waggl is an Employee Voice platform that crowdsources real-time insight to drive faster action and alignment around critical business topics. Inspired by the waggle dance honeybees do to communicate vital information, Waggl believes every voice matters. Unlike heavy surveys or basic pulse tools, Waggl is a dialogue-first approach to engagement that creates shared ownership through inclusive team-based action planning.

With a seasoned Executive Team and premiere customers including Freddie Mac, Paychex, Heineken, 3M, Mastercard, UCSF Medical Center, McGraw Hill, Taylor Morrison and Parsons, Waggl partners with leading enterprises to harness the collective intelligence of their people. For more information and an expanded customer list, please visit https://www.waggl.com.

Share article on social media or email:

United Church of God adopts national webcast for weekly service, suspends in-person gatherings for hundreds of congregations


The United Church of God is active on every inhabited continent.

The United Church of God, an International Association, is active on every inhabited continent.

We invite any and all to join us online…God is indeed a refuge for those who seek Him.

“The safety and well-being of our members and families comes first, so we have adopted an expanded online format for our church services on the weekly Sabbath,” said Victor Kubik, president of the United Church of God, an International Association. “This will continue for the next several weeks, allowing the time needed for this coronavirus crisis to safely abate.”

“We invite any and all to join us online on Saturdays at 2:30 p.m. EDT,” he continued. “Although I know all of our members in hundreds of congregations worldwide would prefer to worship and fellowship in person, this online church service gives us all an opportunity to be united together regardless of national borders or inability to travel.”

The United Church of God is also exploring opportunities for online hymn sings and songs of praise. The URL for the global online service is https://www.ucg.org/webcast.

“We consider these positive actions to be biblical in nature, and remain supportive of our respective governments and public health departments in both their self-quarantine measures and setting aside a time of prayer to seek and honor God,” Mr. Kubik said. “God is indeed a refuge for those who seek Him.”

The church first suspended services in the United States and international areas on March 14. Steve Myers, a host of the Beyond Today television program and local Cincinnati pastor, delivered the online sermon from the church’s home office.

Interested people can also access a wide variety of archived sermons from United Church of God ministers and presentations of the Beyond Today television program at https://www.ucg.org/. Search for topics online.

Local congregations of the United Church of God in cities around the world will also be making arrangements for online worship services and opportunities to worship together for the Christian Passover and the contemporary observation of the Days of Unleavened Bread from a New Testament Christian perspective.

“Observing these days is critically important to us, as we mark the death and sacrifice of our Lord and Savior Jesus Christ as our Passover lamb,” said Mr. Kubik. “We as modern day disciples of Jesus Christ follow the admonition of the apostle Paul, as he instructed the disciples living in the ancient Greek city of Corinth, ‘Let us therefore celebrate the festival, not with the old leaven, the leaven of malice and evil, but with the unleavened bread of sincerity and truth’” (1 Corinthians 5:8, English Standard Version).

Biblical scholars note that this statement referred to the Greek Christians in Corinth observing the Days of Unleavened Bread, a period of seven days where disciples of Jesus Christ remove leavened products and refrain from eating same. “The ‘puffing up’ nature of leaven is pictured as a metaphor for the process that leads to Christian sin,” explained Mr. Kubik. “During His ministry, Jesus Christ magnified the traditional Hebrew understanding of the Passover and high days, setting us an example.”

The annual Passover service will now be conducted by baptized members in their homes, with an option to link to a live webcast. The Passover service, which includes the taking of a small amount of wine and unleavened bread as the biblical symbols of the blood and sacrifice of Jesus Christ, will be conducted after sunset on Wednesday, April 8. The first Holy Day of the seven-day Festival of Unleavened Bread will take place on April 9, followed by a second Holy Day on April 15. Online services will be conducted on those days.

The Church also changed its planned annual business meeting of church ministers at its General Conference of Elders (GCE) in early May, to a videoconference. Church GCE activities required by the Church’s Bylaws will be conducted online.

About the United Church of God, an International Association: More information about the United Church of God is available at http://www.ucg.org . The Church publishes a Bible study guide titled “God’s Holy Day Plan – The Promise of Hope for All Mankind ,”which describes the biblical foundation for the ancient Hebrew Holy Days in detail. The Church publishes the Beyond Today magazine and sponsors the weekly television program (now airing on WGN-America on Saturdays and Sundays) of the same name: Beyond Today .

Share article on social media or email:

AltaPointe offers tips for people with mental illness experiencing quarantine and social distancing


News Image

As COVID-19 spreads across the nation, the Centers for Disease Control and other healthcare experts call for us to practice social distancing and, in some cases, self-quarantine to help stop the spread of the coronavirus. However, social distancing and quarantine can be especially difficult for people who have underlying mental health issues.

Cindy Gipson, Ph.D., serves as the assistant director of intensive services for AltaPointe Health and offers the following tips for staying connected in positive ways during these uncertain times.


  • Tune out media that can produce anxiety or fear. It is okay to stay informed but do not spend more than 30 minutes a day on news media. Find out what you need to know to be safe then tune out.
  • Tune in to your support system. Reach out to family and friends by text or phone so that you stay connected and share information about your day, your hobbies, or your concerns.
  • Tune out, negative people. You don’t need doom and gloom right now. Keep it positive or keep it moving!
  • Tune in to your resources. If you need more support than you can get from friends and family, reach out to your mental health professionals. We are still here to make sure you get what you need, and there are many ways we can help by phone.
  • Remember, YOU control the ability to tune in or tune out. Focus on the positive and do something that makes you feel productive at home and take comfort in talking with friends and family by phone. We are going to get through with the support of each other!

AltaPointe Health is Alabama’s largest and most comprehensive health and human services organization and psychiatric hospital system. It is the second largest in the southeastern US serving Mobile, Baldwin, and Washington counties in south Alabama and Clay, Coosa, Randolph, and Talladega counties to the north. Each year it provides mental health, substance abuse, and intellectual disability services to more than 35,000 children and adults.

Share article on social media or email:

Visiting Care Giving Services Follows CDC Recommended Protocols to Keep Seniors Safe During COVID-19 Pandemic


At Visiting Care Giving Services, our top priority is the safety and wellbeing of our clients, which is why we’re vigilantly following recommended guidelines related to the current COVID-19 (coronavirus) pandemic, including:

  • Sanitizing and disinfecting items that may be brought into a client’s home, such as a caregiver’s personal belongings
  • Ensuring the health of our caregiving staff, and keeping them out of clients’ homes when exhibiting any symptoms of illness, if they’ve recently traveled out of the country, or if there’s the potential that they were exposed to someone who may be at risk for COVID-19
  • Reinforcing proper procedures with staff for preventing the spread of illness, such as effective handwashing methods
  • Staying on top of the latest news and recommendations from both the World Health Organization and the Centers for Disease Control and Prevention (CDC)

We are always available to answer any questions or address any concerns you may have. We’re committed, as always, to providing the highest quality care for our clients in the environment that is most safe and comfortable, especially during this challenging time – at home.

To learn more about Visiting Care Giving Services, and for ongoing updates to our response to this situation, visit http://www.visitingcaregiving.com.

About Visiting Care Giving Services

Visiting Care Giving Services is a locally owned and operated home care agency that provides both medical and non-medical home care for Missouri residents in St. Charles, St. Peters, Wentzville, O’Fallon, Chesterfield and Washington. Our highly customized care solutions help clients maintain independence and dignity in the comfort and familiarity of home. To learn more, visit us at http://www.visitingcaregiving.com.

Share article on social media or email:

Van Dyk Health Care issues official statement on recent news involving Family of Caring at Montclair


Van Dyk Health Care, which sold its skilled nursing facilities in Montclair and Ridgewood to the current operator, Family of Caring, on October 3, 2018 and is not involved in the operations of these facilities in any capacity, has issued the following statement about the recent news involving Family of Caring at Montclair.

“We are devastated to learn about the recent tragedy at Family of Caring’s skilled nursing facility in Montclair. Our thoughts and prayers are with the victims and their loved ones during this difficult time. We hope that everyone involved is following all precautionary measures as recommended by the Centers for Disease Control & Prevention, the New Jersey Department of Health and any trade associations like American Health Care Association in order to protect the facility’s staff, patients and anyone else interacting with them.”

Van Dyk Health Care, a family-owned care provider with 67 years of serving New Jersey families, offers an extensive continuum of care services for assisted living, memory care, home care and Alzheimer’s day care. Since 1953, the Van Dyk family has taken a personalized approach in caring for residents and families throughout Passaic, Bergen and Essex counties. The company received the #2 national ranking by Fortune for the Best Workplace in Aging Services, the Top Workplace award by North Jersey Media Group, the Women’s Choice Award, and recognition from U.S. News & World Report as one of America’s top care providers.

Van Dyk Park Place, one of the leading assisted living communities in New Jersey, received the 2020 Best of Senior Living Award from SeniorAdvisor.com and the 2020 Member of the Year award from the Hawthorne Chamber of Commerce.

# # #

Share article on social media or email:

Clinical Trials Website, ClinicalConnection.com, will List Coronavirus Clinical Trials at No Cost; Public Can Register to Receive Alerts about COVID-19 Clinical Trials


Clinical-Connection-Patient-Recruiting-Services

ClinicalConnection Digital Patient Recruitment

Given our ability to rapidly reach hundreds of thousands of people interested in clinical trials participation, we saw a unique opportunity to be part of the solution — helping researchers hasten patient enrollment in vaccine and other COVID-19 clinical trials.

ClinicalConnection.com, a leading website for clinical trial information and notifications, is offering to list all clinical trials for the novel Coronavirus (COVID-19) free-of-charge on its searchable clinical trials website and notification engine. Members of ClinicalConnection.com who have indicated an interest in COVID-19 clinical trials will be alerted if they reside near a study site. Each year over three million people visit http://www.clinicalconnection.com to search for clinical trials in their community and more than 650,000 members currently receive clinical trials notifications across numerous diseases and medical conditions.

“Speed is essential in effectively dealing with the unprecedented COVID-19 pandemic. Given our ability to rapidly reach hundreds of thousands of people interested in clinical trials participation, we saw a unique opportunity to be part of the solution — helping researchers hasten patient enrollment in vaccine and other COVID-19 clinical trials,” said Greg Conlan, Director of Operations for ClinicalConnection.com. Therefore, effective immediately ClinicalConnection.com will waive the usual listing and outreach fees for pharmaceutical companies, clinical research sites and hospitals who post clinical trials for COVID-19 on ClinicalConnection.com. The company will automatically apply a free listing discount when any COVID-19 study is posted. For additional information, please email: info@clinicalconnection.com or call 1-800-887-0639.

Individuals who have not yet registered on ClinicalConnection.com to receive free Clinical Trial Alerts are urged to do so at https://www.clinicalconnection.com/study-participant/join. They will be able to specify their interest in Clinical Trial Alerts about COVID-19 as well as study alerts for other diseases and medical conditions. Current members can update their profiles at any time to request notifications about newly listed clinical trials for COVID-19.

Research to develop and test a vaccine to protect against COVID-19 is ramping up quickly. The first clinical trial of a vaccine in Seattle, WA, testing 45 young, healthy volunteers is underway. Other clinical trial approaches may be available in the future. Associated Press (AP) reports that some researchers are hoping to quickly develop vaccines that provide temporary protection while a longer-lasting option is developed. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) says even if initial tests go well, it could take up to 18 months before a vaccine offering longer protection is available for widespread use.

Clinical study enrollment is one of the highest barriers to timely completion of clinical trials — which can ultimately impact time-to-market for new pharmaceuticals and medical devices. Headquartered in Boston, Massachusetts, Clinical Connection, Inc. provides a patient recruiting clinical trials platform designed to help the clinical trials industry meet enrollment goals for clinical research studies. Clients include pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations (CROs) academic and independent clinical research centers, hospitals and physician practices engaged in clinical research. ClinicalConnection.com has listed over 40,000 clinical trials in the US and worldwide and has referred over one million participants to clinical research studies.

Contact Information

Dan Wilde

Clinical Connection, Inc

https://www.clinicalconnection.com/

info@clinicalconnection.com+1 800-887-0639 Ext: 912

Share article on social media or email:

Acutis Diagnostics Announces Availability of SARS-CoV-2 Testing


Acutis Diagnostics, a clinical diagnostics laboratory headquartered in New York, announced today that it has released a multiplex laboratory test for the detection of SARS-CoV-2, the causative agent of COVID-19. The assay will be available beginning Monday, March 23, 2020 and will be run under an Emergency Use Authorization granted to Acutis from the FDA. The assay will use a standard nasopharyngeal specimen from which Acutis will extract viral RNA and then test for the presence of key genes that can be used to identify its presence.

“We are very proud of our outstanding research and development team who have worked tirelessly on this validation,” commented Jibreel Sarij, CEO. “While offering an assay based on an EUA obtained by a diagnostic manufacturer rather pursuing our own might have been simpler, our team felt that by using our skill set honed in the design of our other molecular assays, it would allow us to provide the most effective solution to our clients. This process, whereby we performed prescribed validation steps using various sample types, provided us with a deeper understanding of the assay than we might have experienced otherwise. We are thankful to our development partners who have worked diligently along with our scientists, not only in providing some of the key validation material but also in ensuring us that they will be able to keep up with the demand that we have been seeing nationwide.”

The Acutis SARS-CoV-2 test is a multiplex assay that targets three key genes—ORF1ab, N, and E, that scientists believe are key to accurately identifying the presence of the virus in patient samples. This assay is to be ordered under the guidelines issued by CDC and various departments of health to identify the presence of the virus in symptomatic patients who have tested negative for other respiratory viruses.

For further information, please visit http://www.acutis.com.

Share article on social media or email: